Ever Source Wealth Advisors, LLC Voyager Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 202 shares of VYGR stock, worth $1,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202
Previous 155
30.32%
Holding current value
$1,020
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VYGR
# of Institutions
120Shares Held
32.7MCall Options Held
32.9KPut Options Held
22.7K-
Black Rock Inc. New York, NY5.31MShares$26.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.8MShares$24.2 Million0.26% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$19.8 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$16.2 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$7.45 Million0.24% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $195M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...